The Microbiome of Oesophageal Squamous Cell Carcinoma

计划入组 200 人 · 首次发布于 2020 年 6 月 11 日

NeoAdjuvant Therapy With Immunoreagent (SHR-1316) for Resectable Oesophageal Squamous Cell carciNoma

计划入组 30 人 · 首次发布于 2020 年 1 月 2 日

Perioperative Tislelizumab Plus Chemotherapy for Resectable Thoracic Oesophageal Squamous Cell Carcinoma

计划入组 73 人 · 首次发布于 2023 年 9 月 28 日

NANT Squamous Cell Carcinoma Vaccine

GPR87 antagonists (squamous cell carcinoma)

NUCC-0227383

Gamida Cell

Israel

GAMIDA CELL INC.

United States

CELL GENESYS INC.

United States

Endostar Continuous Infusion Enhances Chemoradiotherapy Efficacy in Esophageal Cancer

BeiGene's Tevimbra Approved in Israel for Advanced Esophageal Cancer

EMA Recommends Nivolumab and Ipilimumab Combination for dMMR/MSI-H Metastatic Colorectal Cancer